# ImmVue Therapeutics Inc. — Form D/A

ImmVue Therapeutics Inc. of TORONTO, A6, a company, filed a Form D amendment with the SEC on 2024-04-18. The offering totals $529K, of which $529K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-04-18
- Form: D/A
- Accession: 0000899797-24-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $529K
- Amount sold: $529K
- Minimum investment: $50K
- Investors: 3
- Date of first sale: 2024-01-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-508035

## Issuer

- Name: ImmVue Therapeutics Inc.
- CIK: 0002009514
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 252 RUSSELL HILL RD, TORONTO, A6, M4V 2T2
- Phone: 416-834-5537

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Sandy Der | Director | Toronto, A6 |
| Joon-Hyung John Kim | Director | Toronto, A6 |
| David Moon | Director | Toronto, A6 |
| Jayan John Nagendran | Director | Toronto, A6 |
| Sandy Der | Executive Officer | Toronto, A6 |
| David Moon | Executive Officer | Toronto, A6 |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-03-19](https://search.stillhousedata.com/formd/0000899797-24-000003) | D | $1.2M | $154K |

## More

- [CIK 2009514 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2009514&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000899797-24-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.